Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “IO Biotech ApS”

14 pharma patents match "IO Biotech ApS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 14
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 14 pharmaceutical patents matching "IO Biotech ApS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

14 results for “IO Biotech ApS” · 30,257 patents in full index Clear search

  1. US 12234288

    Immunogenic arginase 2 polypeptides

    IO Biotech ApS · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  2. US 12233103

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  3. US 12215135

    PDL2 compounds

    IO Biotech ApS · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  4. US 12194081

    ARGINASE1 polypeptides

    IO Biotech ApS · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  5. US 12187782

    PDL1 peptides for use in cancer vaccines

    IO Biotech ApS · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  6. US 11981944

    Immunogenic arginase peptides

    IO Biotech ApS · Granted May 14, 2024 · Expires May 9, 2044

    granted
  7. US 11878053

    Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof

    IO Biotech ApS · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  8. US 11648302

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted May 16, 2023 · Expires May 11, 2043

    granted
  9. US 11447537

    PDL2 compounds

    IO Biotech ApS · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  10. US 11324813

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted May 10, 2022 · Expires May 5, 2042

    granted
  11. US 11298413

    Vaccine compositions comprising C—C motif chemokine 22 (CCL22) or fragments thereof

    IO Biotech ApS · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted
  12. US 10858642

    Immunogenic arginase peptides

    IO Biotech ApS · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted
  13. US 10258678

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted
  14. US 9433666

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted